MedTrace Logo

High-Risk prostatE Cancer radiatiOn Versus surgERy

NCT05931419 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 837

Last updated 2026-05-22

No results posted yet for this study

Summary

Prospective cohort study comparing robot-assisted radical prostatectomy and external beam radiotherapy +/- androgen deprivation therapy for high-risk non-metastatic prostate cancer in terms of health-related quality of life, functional outcomes, cost-effectiveness, progression-free survival and distant metastasis-free survival.

Conditions

Sponsors & Collaborators

  • Comprehensive Cancer Centre The Netherlands

    lead OTHER

Principal Investigators

  • Katja Aben, PhD · Comprehensive Cancer Centre The Netherlands

  • Igle Jan de Jong, MD, PhD · University Medical Center Groningen

  • Floris Pos, MD, PhD · Netherlands Cancer Institute/ Antoni van Leeuwenhoek

  • Berdine Heesterman, MD, PhD · Comprehensive Cancer Centre The Netherlands

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2029-09-30
Completion
2030-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05931419 on ClinicalTrials.gov